World Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return 3 min 0 By Reuters
BHEKISISA A dose of their own medicine — should SA force big drugmakers to let others make insulin pens too? 7 min 3 By Christina Pitt
DIABETES ALARM Doctors Without Borders calls on big pharma to continue supply of insulin pens as contract ends 4 min 0 By Estelle Ellis
THE CONVERSATION The rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs 5 min 1 By Sebastian Furness
COMPANIES Aspen’s Novo Nordisk deal a ‘feather in our cap’ and an NCD battle boost - top executive 4 min 0 By Georgina Crouth
HEALTHCARE BOOST Aspen’s Covid vaccine facility in Gqeberha switches to making insulin for Africa 3 min 1 By Estelle Ellis
BHEKISISA CENTRE FOR HEALTH JOURNALISM Global stocks of diabetes drug Ozempic drained by doctors prescribing it for weight loss 6 min 0 By Zano Kunene
